Crinetics pharmaceuticals announces july 2024 inducement grants under nasdaq listing rule 5635(c)(4)

San diego, july 10, 2024 (globe newswire) -- crinetics pharmaceuticals, inc. (nasdaq: crnx) today announced that on july 10, 2024, the compensation committee of crinetics' board of directors granted non-qualified stock option awards to purchase an aggregate of 137,900 shares of its common stock to eighteen new non-executive employees under the crinetics pharmaceuticals, inc. 2021 employment inducement incentive award plan (the “2021 inducement plan”). the stock options were granted as inducements material to the employees entering into employment with crinetics in accordance with nasdaq listing rule 5635(c)(4).
NDAQ Ratings Summary
NDAQ Quant Ranking